We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

131 hedge funds and large institutions have $447M invested in Rigel Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 58 increasing their positions, 20 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

190% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 20

100% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 15

12% more funds holding

Funds holding: 117 → 131 (+14)

6% more call options, than puts

Call options by funds: $831K | Put options by funds: $782K

0.25% more ownership

Funds ownership: 9.41% → 9.65% (+0.25%)

9% less capital invested

Capital invested by funds: $490M → $447M (-$43.5M)

Holders
131
Holders Change
+14
Holders Change %
+11.97%
% of All Funds
3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
58
Reduced
20
Closed
15
Calls
$831K
Puts
$782K
Net Calls
+$49K
Net Calls Change
-$3.66M

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$10.7M
2
State Street
State Street
Massachusetts
+$10.7M
3
TA
Tamarack Advisers
California
+$9.34M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.71M
5
BlackRock
BlackRock
New York
+$8.23M

Top Sellers

1
GPP
Great Point Partners
Connecticut
-$18.4M
2
BC
Boxer Capital
California
-$10M
3
BBA
Baker Bros. Advisors
New York
-$5.26M
4
JGC
J. Goldman & Co
New York
-$2.95M
5
DCM
DAFNA Capital Management
California
-$2.72M
Name Holding Trade Value Shares
Change 		Change in
Stake
SSA
51
Schonfeld Strategic Advisors
New York
$927K +$1.17M +32,760 New
BRF
52
B. Riley Financial
California
$920K +$1.16M +32,500 New
TA
53
Teachers Advisors
New York
$840K +$111K +3,106 +12%
Swiss National Bank
54
Swiss National Bank
Switzerland
$767K +$148K +4,158 +18%
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
$715K +$98.9K +2,780 +12%
VEA
56
Virtus ETF Advisers
New York
$617K +$18.2K +511 +2%
Walleye Trading
57
Walleye Trading
New York
$584K +$734K +20,627 New
TI
58
Telemetry Investments
New York
$509K +$196K +5,500 +44%
Two Sigma Advisers
59
Two Sigma Advisers
New York
$447K +$38.8K +1,090 +7%
RhumbLine Advisers
60
RhumbLine Advisers
Massachusetts
$440K +$77.4K +2,175 +16%
New York State Common Retirement Fund
61
New York State Common Retirement Fund
New York
$427K +$13.9K +390 +3%
DCM
62
DAFNA Capital Management
California
$389K -$2.72M -76,433 -85%
TRSOTSOK
63
Teachers Retirement System of the State of Kentucky
Kentucky
$383K +$232K +6,510 +93%
Manulife (Manufacturers Life Insurance)
64
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$366K +$59.1K +1,661 +15%
Los Angeles Capital Management
65
Los Angeles Capital Management
California
$351K +$441K +12,393 New
Axa
66
Axa
France
$338K +$426K +11,960 New
NSEDCP
67
NJ State Employees Deferred Compensation Plan
New Jersey
$311K -$142K -4,000 -27%
AIG
68
American International Group
New York
$304K +$46K +1,293 +14%
Neuberger Berman Group
69
Neuberger Berman Group
New York
$289K +$363K +10,200 New
MIM
70
MetLife Investment Management
New Jersey
$287K +$125K +3,509 +53%
ProShare Advisors
71
ProShare Advisors
Maryland
$256K +$13.7K +384 +4%
Squarepoint
72
Squarepoint
New York
$254K +$320K +8,982 New
Wells Fargo
73
Wells Fargo
California
$246K -$7.72K -217 -2%
State of Wisconsin Investment Board
74
State of Wisconsin Investment Board
Wisconsin
$241K – – –
State Board of Administration of Florida Retirement System
75
State Board of Administration of Florida Retirement System
Florida
$232K – – –
1 2
3
4 5

RIGL Hedge Fund Activity: Q2 2018 in Review

131 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q2 2018, worth a combined $447M — down 8.9% from $490M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new RIGL positions and 15 closed out — a net gain of 15 holders — while 58 added to existing stakes and 20 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $10.7M. The largest seller was Great Point Partners, cutting an estimated $18.4M.

  • 131 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q2 2018, up from 117 in Q1 2018.
  • Funds reported $447M of Rigel Pharmaceuticals stock for Q2 2018, down 8.9% quarter-over-quarter.
  • 30 funds opened new Rigel Pharmaceuticals positions in Q2 2018 and 15 closed out, a net change of +15 holders.
  • The largest Rigel Pharmaceuticals buyer in Q2 2018 was Citadel Advisors, an estimated $10.7M added.
  • The largest Rigel Pharmaceuticals seller in Q2 2018 was Great Point Partners, an estimated $18.4M sold.

Based on aggregated 13F filings for Q2 2018.